Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gissette Reyes-Soffer

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Opinion in Lipidology|April 26, 2021
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular riskGissette Reyes-Soffer
Current Opinion in Endocrinology, Diabetes, and Obesity|January 22, 2021
Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease risk: current status and treatmentsGissette Reyes-Soffer
Pharmacological Research|May 25, 2021
Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammationGissette Reyes-Soffer, Marit Westerterp
Current Opinion in Lipidology|November 5, 2013
Niacin: a long history, but a questionable futureHenry N Ginsberg, Gissette Reyes-Soffer
The Journal of Clinical Investigation|August 27, 2019
Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?Henry N Ginsberg, Gissette Reyes-Soffer
Best Practice & Research. Clinical Endocrinology & Metabolism|February 24, 2023
Supporting evidence for lipoprotein(a) measurements in clinical practiceAnastasiya Matveyenko, Marianna Pavlyha, Gissette Reyes-Soffer
Journal of Lipid Research|July 20, 2017
The metabolism of lipoprotein (a): an ever-evolving storyGissette Reyes-Soffer, Henry N Ginsberg, Rajasekhar Ramakrishnan
Current Opinion in Lipidology|March 11, 2024
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolismJing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Expert Opinion on Pharmacotherapy|March 24, 2011
Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitusGissette Reyes-Soffer, Carlos Rondon-Clavo, Henry N Ginsberg
Current Cardiology Reports|January 30, 2017
Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 DiabetesMaryam Khavandi, Francisco Duarte, Henry N Ginsberg, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Opinion in Lipidology|April 26, 2021
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular riskGissette Reyes-Soffer
Current Opinion in Endocrinology, Diabetes, and Obesity|January 22, 2021
Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease risk: current status and treatmentsGissette Reyes-Soffer
Pharmacological Research|May 25, 2021
Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammationGissette Reyes-Soffer, Marit Westerterp
Current Opinion in Lipidology|November 5, 2013
Niacin: a long history, but a questionable futureHenry N Ginsberg, Gissette Reyes-Soffer
The Journal of Clinical Investigation|August 27, 2019
Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?Henry N Ginsberg, Gissette Reyes-Soffer
Best Practice & Research. Clinical Endocrinology & Metabolism|February 24, 2023
Supporting evidence for lipoprotein(a) measurements in clinical practiceAnastasiya Matveyenko, Marianna Pavlyha, Gissette Reyes-Soffer
Journal of Lipid Research|July 20, 2017
The metabolism of lipoprotein (a): an ever-evolving storyGissette Reyes-Soffer, Henry N Ginsberg, Rajasekhar Ramakrishnan
Current Opinion in Lipidology|March 11, 2024
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolismJing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Expert Opinion on Pharmacotherapy|March 24, 2011
Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitusGissette Reyes-Soffer, Carlos Rondon-Clavo, Henry N Ginsberg
Current Cardiology Reports|January 30, 2017
Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 DiabetesMaryam Khavandi, Francisco Duarte, Henry N Ginsberg, et al.
Pageof 5